Issued quarterly by independent publisher, Pan European Networks Ltd, Health Europa is a digital publication that reports on the latest trends and developments in health and healthcare from across Europe and beyond. The publication regularly includes coverage of research, innovation, health policy and new technologies. Health Europa’s latest Spring issue focuses on the fast-growing worlds of infection prevention, control and digital health technology.

This latest issue features a timely piece entitled, “Ultracold storage to accelerate medical innovation,” highlighting how investment in ultra-low temperature (ULT) freezers for COVID-19 vaccine distribution and administration is readying the world for a new wave of medicine. This article shares insightful ideas and answers to several key questions related to the future role of the ultracold chain, including:

  • What classifies a temperature as “ultracold”?
  • Why has ultracold storage become so important in addressing COVID-19?
  • Why is the ultracold chain becoming a key enabler of next generation medicine?

Stirling Freezers Cited for Key Advantages

In this piece, Health Europa also highlights the unique advantages of Stirling Ultracold freezers in equitably addressing the worldwide pandemic and why many of these same benefits ideally position our products to play a critical role in enabling developmental, translational, manufacturing and patient administration phases for next generation drugs and treatments. Featured Stirling advantages include:

  • Infrastructure readiness
  • Portability for clinical deployment
  • Cloud-based temperature monitoring
  • Wider set point temperature range

We applaud Health Europa for bringing this timely and relevant article to their global readership. Click here to read the full article.